Login / Signup

Tranexamic Acid to Prevent Obstetrical Hemorrhage after Cesarean Delivery.

Luis D PachecoRebecca G CliftonGeorge R SaadeSteven J WeinerSamuel ParryJohn M ThorpMonica LongoAshley SalazarWendy DaltonAlan T N TitaCynthia Gyamfi-BannermanSuneet P ChauhanTorri D MetzKara RoodDwight J RouseJennifer L BailitWilliam A GrobmanHyagriv N SimhanGeorge A Maconesnull null
Published in: The New England journal of medicine (2023)
Prophylactic use of tranexamic acid during cesarean delivery did not lead to a significantly lower risk of a composite outcome of maternal death or blood transfusion than placebo. (Funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development; ClinicalTrials.gov number, NCT03364491.).
Keyphrases
  • endothelial cells
  • induced pluripotent stem cells
  • birth weight
  • quality improvement
  • pluripotent stem cells
  • pregnancy outcomes
  • clinical trial
  • randomized controlled trial
  • body mass index
  • phase iii